386 related articles for article (PubMed ID: 12490598)
21. Physiological evidence for β3-adrenoceptor in frog (Rana esculenta) heart.
Mazza R; Angelone T; Pasqua T; Gattuso A
Gen Comp Endocrinol; 2010 Nov; 169(2):151-7. PubMed ID: 20709064
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of beta3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies.
Sarma DN; Banwait K; Basak A; DiMarino AJ; Rattan S
J Pharmacol Exp Ther; 2003 Jan; 304(1):48-55. PubMed ID: 12490574
[TBL] [Abstract][Full Text] [Related]
23. Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
Valet P; Taouis M; Tran MA; Montastruc P; Lafontan M; Berlan M
Br J Pharmacol; 1989 May; 97(1):229-39. PubMed ID: 2566353
[TBL] [Abstract][Full Text] [Related]
24. Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.
Shen YT; Zhang H; Vatner SF
J Pharmacol Exp Ther; 1994 Jan; 268(1):466-73. PubMed ID: 7905532
[TBL] [Abstract][Full Text] [Related]
25. Role of the beta(3)-adrenoceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants.
Takeda H; Yamazaki Y; Akahane M; Igawa Y; Ajisawa Y; Nishizawa O
J Pharmacol Exp Ther; 2000 Jun; 293(3):939-45. PubMed ID: 10869395
[TBL] [Abstract][Full Text] [Related]
26. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
[TBL] [Abstract][Full Text] [Related]
27. SR59230A blocks beta3-adrenoceptor-linked modulation of upcoupling protein-1 and leptin in rat brown adipocytes.
Tonello C; Dioni L; Briscini L; Nisoli E; Carruba MO
Eur J Pharmacol; 1998 Jul; 352(1):125-9. PubMed ID: 9718277
[TBL] [Abstract][Full Text] [Related]
28. Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan.
Lenard NR; Gettys TW; Dunn AJ
J Pharmacol Exp Ther; 2003 May; 305(2):653-9. PubMed ID: 12606631
[TBL] [Abstract][Full Text] [Related]
29. L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.
Forrest MJ; Hom G; Bach T; Candelore MR; Cascieri MA; Strader C; Tota L; Fisher MH; Szumiloski J; Ok HO; Weber AE; Wyvratt M; Vicario P; Marko O; Deng L; Cioffe C; Hegarty-Friscino B; MacIntyre E
Eur J Pharmacol; 2000 Oct; 407(1-2):175-81. PubMed ID: 11050305
[TBL] [Abstract][Full Text] [Related]
30. [Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta3-adrenoceptors].
Toumaniantz G; Seze C; Serpillon S; Menoret S; Tesson L; Anégone I; Gauthier C
Arch Mal Coeur Vaiss; 2005; 98(7-8):836-40. PubMed ID: 16220757
[TBL] [Abstract][Full Text] [Related]
31. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.
Liu YL; Toubro S; Astrup A; Stock MJ
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):678-85. PubMed ID: 8574280
[TBL] [Abstract][Full Text] [Related]
32. Beta-adrenoreceptor antagonist potency and pharmacodynamics of ASL-8123, the primary acid metabolite of esmolol.
Shaffer JE; Quon CY; Gorczynski RJ
J Cardiovasc Pharmacol; 1988 Feb; 11(2):187-92. PubMed ID: 2452313
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
Donckier JE; Massart PE; Van Mechelen H; Heyndrickx GR; Gauthier C; Balligand JL
Eur J Clin Invest; 2001 Aug; 31(8):681-9. PubMed ID: 11473569
[TBL] [Abstract][Full Text] [Related]
34. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Montastruc JL; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
Fundam Clin Pharmacol; 1999; 13(2):180-6. PubMed ID: 10226761
[TBL] [Abstract][Full Text] [Related]
35. Bromocriptine-induced tachycardia in conscious rats: blunted response following isoproterenol pretreatment for 5 days.
Lahlou S; Duarte GP
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):165-74. PubMed ID: 9777039
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a secondary state of the human beta3-adrenoceptor.
Baker JG
Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
[TBL] [Abstract][Full Text] [Related]
37. Involvement of lipoic acid in plasma metabolites, hepatic oxygen consumption, and metabolic response to a beta-agonist in broiler chickens.
Hamano Y; Sugawara S; Kamota Y; Nagai E
Br J Nutr; 1999 Dec; 82(6):497-503. PubMed ID: 10690165
[TBL] [Abstract][Full Text] [Related]
38. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats.
Lahlou S; Lima GC; Leão-Filho CS; Duarte GP
Can J Physiol Pharmacol; 2000 Mar; 78(3):260-5. PubMed ID: 10721819
[TBL] [Abstract][Full Text] [Related]
39. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
40. β2 adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats.
Zlotnik A; Klin Y; Gruenbaum BF; Gruenbaum SE; Ohayon S; Leibowitz A; Kotz R; Dubilet M; Boyko M; Shapira Y; Teichberg VI
J Neurosurg Anesthesiol; 2012 Jan; 24(1):30-8. PubMed ID: 21979171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
